TREX1 Protein
Overview
Three Prime Repair Exonuclease 1 (TREX1), also known as DNase III, is a 33.9 kDa cytoplasmic exonuclease encoded by the TREX1 gene on chromosome 3. This enzyme catalyzes the degradation of single-stranded DNA (ssDNA) and plays a critical role in regulating cellular DNA metabolism and innate immune homeostasis. TREX1 is the most abundant cytoplasmic 3' to 5' exonuclease in mammalian cells and functions as a key guardian against aberrant nucleic acid accumulation. Loss-of-function mutations in TREX1 have been associated with several severe neurological conditions, including Aicardi-Goutieres syndrome (AGS), a progressive encephalopathy characterized by brain inflammation and neurodegeneration.
Function/Biology
TREX1 functions primarily as a 3' to 5' exonuclease that processively degrades single-stranded DNA, preventing the accumulation of cytoplasmic nucleic acids that would otherwise trigger innate immune responses. The enzyme localizes predominantly to the cytoplasm, with some activity in the nucleus, and requires intact catalytic residues (Asp-10, Glu-48, and Asp-65) for enzymatic activity.
...TREX1 Protein
Overview
Three Prime Repair Exonuclease 1 (TREX1), also known as DNase III, is a 33.9 kDa cytoplasmic exonuclease encoded by the TREX1 gene on chromosome 3. This enzyme catalyzes the degradation of single-stranded DNA (ssDNA) and plays a critical role in regulating cellular DNA metabolism and innate immune homeostasis. TREX1 is the most abundant cytoplasmic 3' to 5' exonuclease in mammalian cells and functions as a key guardian against aberrant nucleic acid accumulation. Loss-of-function mutations in TREX1 have been associated with several severe neurological conditions, including Aicardi-Goutieres syndrome (AGS), a progressive encephalopathy characterized by brain inflammation and neurodegeneration.
Function/Biology
TREX1 functions primarily as a 3' to 5' exonuclease that processively degrades single-stranded DNA, preventing the accumulation of cytoplasmic nucleic acids that would otherwise trigger innate immune responses. The enzyme localizes predominantly to the cytoplasm, with some activity in the nucleus, and requires intact catalytic residues (Asp-10, Glu-48, and Asp-65) for enzymatic activity.
The protein operates through several physiological pathways. During reverse transcription and other DNA synthesis processes, TREX1 degrades abortive DNA products that could activate pattern recognition receptors. Additionally, TREX1 regulates the turnover of Okazaki fragments—short DNA segments synthesized during lagging strand DNA replication—preventing their accumulation. The enzyme also functions in processing defective viral DNA following retroviral infection, thereby limiting viral DNA-induced immune activation.
TREX1 interacts with several protein partners including RNase H2 and components of the SAMHD1 complex, collectively forming a network that controls cytoplasmic nucleic acid metabolism. These interactions coordinate the degradation of both DNA and RNA substrates, maintaining cellular homeostasis.
Role in Neurodegeneration
TREX1 mutations cause Aicardi-Goutieres syndrome type 1 (AGS1), a rare autosomal recessive disorder characterized by early-onset progressive encephalitis, leukoencephalopathy, basal ganglia calcification, and intellectual disability. The neurodegeneration in AGS results from aberrant activation of interferon regulatory factor 3 (IRF-3) and nuclear factor-kappa B (NF-κB) signaling pathways, triggered by accumulated cytoplasmic ssDNA.
In TREX1-deficient neurons, impaired ssDNA degradation leads to recognition by cyclic GMP-AMP synthase (cGAS), which synthesizes 2',3'-cyclic GMP-AMP (cGAMP). This triggers stimulator of interferon genes (STING)-mediated signaling cascades that generate excessive type I interferon responses. This chronic interferon-alpha/beta overproduction causes sustained neuroinflammation, microglial activation, and eventually neuronal apoptosis and degeneration.
TREX1 dysfunction also impairs the removal of abortive DNA products generated by failed or stalled DNA replication forks, particularly in post-mitotic neurons with limited capacity for homologous recombination repair. This leads to persistent DNA damage signals and cellular stress.
Molecular Mechanisms
TREX1 catalyzes DNA degradation through a metal-dependent catalytic mechanism involving two metal ions (typically Mg²⁺ or Mn²⁺) at the active site. The enzyme recognizes ssDNA through its C-terminal zinc-binding domain and positions the DNA substrate for nucleophilic attack by a conserved aspartate residue.
Pathogenic TREX1 mutations fall into several categories: truncating mutations produce non-functional protein lacking catalytic domains, missense mutations impair enzyme activity or substrate binding, and mutations in zinc-coordinating residues disrupt DNA recognition. These mutations consistently result in cytoplasmic ssDNA accumulation and uncontrolled cGAS-STING activation.
Clinical/Research Significance
TREX1 mutations are detected in approximately 30% of AGS cases, making TREX1 the most frequently mutated AGS-associated gene. Beyond AGS, TREX1 polymorphisms have been associated with systemic lupus erythematosus (SLE) and other autoimmune conditions, suggesting broader roles in immune regulation.
Current research focuses on developing therapeutic strategies to suppress excessive interferon signaling in AGS patients, including JAK-STAT pathway inhibitors and STING antagonists. Understanding TREX1 function also provides insights into innate immune sensing mechanisms and the consequences of dysregulated interferon responses in neurodegenerative conditions.
- [[Aicardi-Goutieres Syndrome]] - Primary TREX1-associated disorder
- [[RNase H2]] - Cooperative nucleic acid degradation pathway
- [[cGAS-STING Pathway]] - Downstream immune sensing mechanism
- [[Type I Interferon Response]] - Pathogenic